You are here: Home: Meet The Professors - GIST 1 | 2008: Faculty Affliations and Disclosures

Faculty Affiliations

	Charles D Blanke, MD Professor of Medicine OHSU Cancer Institute Portland, Oregon		Brian Rubin, MD, PhD Director, Soft Tissue Pathology Cleveland Clinic Foundation Cleveland, Ohio
	George D Demetri, MD Director, Ludwig Center at Dana-Farber Cancer Institute and Harvard Medical School Boston, Massachusetts		Jonathan C Trent, MD, PhD Assistant Professor of Medicine Department of Sarcoma Medical Oncology The University of Texas MD Anderson Cancer Center Houston, Texas
	Burton L Eisenberg, MD Professor of Surgery Section of Surgical Oncology Dartmouth Medical School Dartmouth-Hitchcock Medical Center Deputy Director, Norris Cotton Cancer Center Lebanon, New Hampshire

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — Dr Blanke — No real or apparent conflicts of interest to disclose. The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Demetri — Advisory Board: Amgen Inc, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Pfizer Inc; Consulting Agreements: Amgen Inc, Bayer Pharmaceuticals Corporation, Genentech BioOncology, GlaxoSmithKline, GPC Biotech, Novartis Pharmaceuticals Corporation, Pfizer Inc; Stock Ownership: Plexxikon Inc. Dr Eisenberg — Advisory Committee and Speakers Bureau: Novartis Pharmaceuticals Corporation. Dr Rubin — Advisory Committee: Pfizer Inc; Speakers Bureau: Novartis Pharmaceuticals Corporation. Dr Trent — Consulting Agreements: Pfizer Inc.

COMMUNITY PANEL — Drs Glynn, Harwin and Moriarty — No real or apparent conflicts of interest to disclose. Dr Bhardwaj — Advisory Committee: Celgene Corporation, Genentech BioOncology; Consulting Agreements: Novartis Pharmaceuticals Corporation; Paid Research: Genentech BioOncology; Stock Ownership: Celgene Corporation. Dr Cartwright — Advisory Committee: Amgen Inc, Bristol-Myers Squibb Company, Roche Laboratories Inc; Speakers Bureau: Amgen Inc, Bristol-Myers Squibb Company, Genomic Health Inc, Roche Laboratories Inc. Dr Hart — Speakers Bureau: GlaxoSmithKline. Dr Leighton — Paid Research: Amgen Inc, Bristol-Myers Squibb Company, Novartis Pharmaceuticals Corporation; Speakers Bureau: Sanofi-Aventis. Dr Pizzolato — Advisory Committee: Celgene Corporation; Speakers Bureau: ImClone Systems, Sanofi- Aventis. Dr Reeves — Advisory Committee: Bayer Pharmaceuticals Corporation, Celgene Corporation, Genentech BioOncology, Millennium Pharmaceuticals Inc. Dr Safa — Paid Research: MedImmune Inc, Sanofi-Aventis; Speakers Bureau: Genentech BioOncology, Pfizer Inc.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.